arznei-telegramm Logo a-t Kurzlogo
    ❮ a-t 2/2021 a-t ❯
    This is a translation of the table of contents. One article of each issue is translated and freely available.
    table of contents
    NEW ON THE MARKET

    COVID-19 vaccine from AstraZeneca

    Inclisiran (LEQVIO): lower cholesterol with an injection every 6 months?

    THERAPY FROM A CRITICAL VIEWPOINT

    ACE inhibitors and angiotensin II antagonists: withdrawal without influence on the course of COVID-19

    IN BRIEF

    Risks of the appetite suppressant amfepramone to be reassessed

    SIDE EFFECTS

    Gyrase inhibitors: risk of aneurysms not just for risk groups
    free

    Increased risk of cancer with the JAK inhibitor tofacitinib (XELJANZ)

    e a-t ON THE INTERNET

    Bamlanivimab against COVID-19

    arznei-telegramm

    Independent drug information – in English

    Concise, critical evaluations of drugs and medical devices for evidence-based therapy and patient advice on benefits and risks – independent, ad-free and funded exclusively by subscriptions.

    Browse free articles

    Wir schätzen Ihr Feedback

    Nehmen Sie an unserer Umfrage teil!